Loading insider details...
Latest Form 4 (Jun 3, 2026): Grant/Award of 42,507 MDRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Veradigm Inc. (MDRX) | Grant/Award | 42,507 | n/a |
| Mar 4, 2026 | Monopar Therapeutics (MNPR) | Grant/Award | 48,728 | n/a |
| Feb 12, 2026 | AVADEL PHARMACEUTICALS PLC (AVDL) | Disposition to Issuer | 300,000 | n/a |
| Jun 3, 2025 | Veradigm Inc. (MDRX) | Grant/Award | 46,512 | $200.0K |
| May 13, 2025 | AVADEL PHARMACEUTICALS PLC (AVDL) | Grant/Award | 300,000 | n/a |
| Feb 3, 2025 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/Award | 17,950 | n/a |
| Jun 20, 2024 | Veradigm Inc. (MDRX) | Grant/Award | 42,106 | n/a |
| May 23, 2024 | ARDELYX, INC. (ARDX) | Sale | 6,703 | $52.4K |
| Feb 22, 2024 | ARDELYX, INC. (ARDX) | Sale | 6,928 | $60.6K |
| Jan 19, 2024 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/Award | 13,948 | n/a |